Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Nasare
Vijay Nasare, Navi Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080249120 | Pharmaceutical compositions - A pharmaceutical composition in solid form containing at least a therapeutically effective amount of one or more statins in the free acid form is disclosed. | 10-09-2008 |
Vijay Dinanath Nasare, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20080206329 | Modified Release Ciprofloxacin Compositions - Controlled release tablets comprising ciprofloxacin, with hardness and friability of the said tablets ranges between 10 to 70 kiloponds and less than 2% respectively, the compositions releasing at least 80 percent of the total amount of the ciprofloxacin into a pH 1.2 aqueous dissolution medium within about 1 hour. | 08-28-2008 |
Vijay Dinanathji Nasare, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20100129310 | STABILIZED DESLORATADINE COMPOSITION - Stabilized desloratadine-containing pharmaceutical compositions are prepared using complexes formed by combining desloratadine and a resin in the acidic form. | 05-27-2010 |
Vijay Dinanathji Nasare, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20100068269 | TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS - A pharmaceutical dosage form for treating or preventing cardiovascular events comprises therapeutic amounts of: a β-adrenergic receptor antagonist, a diuretic, or both; a cholesterol-lowering agent; an inhibitor of the renin-angiotensin system; and aspirin. | 03-18-2010 |
Vijay Dinanathji Nasare, Nagpur IN
| Patent application number | Description | Published |
|---|---|---|
| 20080260785 | PAROXETINE COMPOSITIONS - The invention relates to pharmaceutical compositions having polymers that release paroxetine in a controlled manner for a prolonged or sustained period of time. An embodiment of the invention provides enhanced bioavailability controlled release pharmaceutical compositions comprising paroxetine or its pharmaceutically acceptable salts, which enables a reduction in its orally administered dose. | 10-23-2008 |